Details of the Drug | DrugMAP

General Information of Drug (ID: DMFB7LF)

Drug Name

JNJ-40929837

Indication

Disease Entry	ICD 11	Status	REF
Asthma	CA23	Phase 2	[1]
------------------------------------------------------------------------------------

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C22H24N4O2S
Canonical SMILES: CC(=O)NC1CC2CCC(C1)N2CC3=CC=C(C=C3)OC4=NC5=C(S4)C=CC=N5
InChI: 1S/C22H24N4O2S/c1-14(27)24-16-11-17-6-7-18(12-16)26(17)13-15-4-8-19(9-5-15)28-22-25-21-20(29-22)3-2-10-23-21/h2-5,8-10,16-18H,6-7,11-13H2,1H3,(H,24,27)/t16?,17-,18+
InChIKey: QZOOKXDESAXLGB-AYHJJNSGSA-N

Cross-matching ID

PubChem CID: 57910975
CAS Number: 1191044-42-4
TTD ID: D0ER9I

References

1	ClinicalTrials.gov (NCT01241422) A Study to Evaluate the Effectiveness of JNJ 40929837 for the Treatment of Asthma Using a Bronchial Allergen Challenge Model. U.S. National Institutes of Health.